A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 10, 2021

Study Completion Date

November 30, 2022

Conditions

Non-small Cell Lung Cancer MetastaticTargetable Oncogenes (EGFR, ALK, ROS1)

Interventions

RADIATION

SBRT with protons or photons

Trial Locations (1)

Massachusetts General Hospital, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT02314364 - A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC | Biotech Hunter | Biotech Hunter